Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.82)
# 706
Out of 5,114 analysts
90
Total ratings
41.86%
Success rate
13.12%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $13.41 | +123.80% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $313.15 | +283.21% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $3.99 | +275.94% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $19.13 | +281.60% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.61 | +1,452.80% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $498.68 | +80.48% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $35.02 | +114.16% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $7.31 | +885.36% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.04 | +298.23% | 5 | Oct 28, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $20.90 | +273.21% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $13.91 | +43.78% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $6.39 | +306.89% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.25 | +221.29% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.91 | +1,894.88% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $40.54 | +257.67% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $28.93 | +76.29% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.47 | +309.56% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $15.11 | +217.67% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $82.00 | +13.41% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $30.09 | +149.25% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $35.19 | +198.38% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $31.45 | +17.65% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.90 | +340.68% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.60 | +4,557.35% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $51.75 | +87.44% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $19.73 | +285.20% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.17 | +383.56% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.34 | +143.21% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $10.34 | +16.05% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.66 | +1,251.35% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.51 | +498.80% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.58 | +187.00% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $47.94 | +66.89% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $87.30 | +6.53% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.18 | +117.72% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.16 | +1,198.45% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $79.61 | -56.04% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $12.89 | +575.20% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.76 | +2,155.15% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $65.09 | +10.62% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $13.96 | +258.13% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.75 | +5,263.37% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.61 | +2,829.88% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.95 | +2,709.36% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $101.80 | -24.36% | 1 | Jul 31, 2020 |
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $13.41
Upside: +123.80%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $313.15
Upside: +283.21%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $3.99
Upside: +275.94%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $19.13
Upside: +281.60%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.61
Upside: +1,452.80%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $498.68
Upside: +80.48%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $35.02
Upside: +114.16%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $7.31
Upside: +885.36%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.04
Upside: +298.23%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $20.90
Upside: +273.21%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $13.91
Upside: +43.78%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.39
Upside: +306.89%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.25
Upside: +221.29%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.91
Upside: +1,894.88%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $40.54
Upside: +257.67%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $28.93
Upside: +76.29%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.47
Upside: +309.56%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $15.11
Upside: +217.67%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $82.00
Upside: +13.41%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $30.09
Upside: +149.25%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $35.19
Upside: +198.38%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $31.45
Upside: +17.65%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.90
Upside: +340.68%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.60
Upside: +4,557.35%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $51.75
Upside: +87.44%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $19.73
Upside: +285.20%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.17
Upside: +383.56%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.34
Upside: +143.21%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $10.34
Upside: +16.05%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.66
Upside: +1,251.35%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.51
Upside: +498.80%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.58
Upside: +187.00%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $47.94
Upside: +66.89%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $87.30
Upside: +6.53%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.18
Upside: +117.72%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.16
Upside: +1,198.45%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $79.61
Upside: -56.04%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $12.89
Upside: +575.20%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.76
Upside: +2,155.15%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $65.09
Upside: +10.62%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $13.96
Upside: +258.13%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.75
Upside: +5,263.37%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.61
Upside: +2,829.88%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.95
Upside: +2,709.36%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $101.80
Upside: -24.36%